[Changes in the treatment of urogenital tuberculosis].
Harold Lipsky, Walter Michael Stadler
Abstract
Harold Lipsky, Walter Michael Stadler
Abstract
Potent antituberculosis drugs and new endourological measures have changed the concept of management of urogenital tuberculosis. This paper presents a report on 56 patients treated with rifampicin, ethambutol and isoniazid for 1 year. Therapy was started in hospital and continued on an ambulatory basis. Reconstructive surgery was carried out as early as 4-5 weeks after commencement of therapy, whereby only destroyed organs wee removed. Follow up continued at three-monthly intervals for a period of 2-5 years after completion of chemotherapy. All patients were cured.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Potent antituberculosis drugs and new endourological measures have changed the concept of management of urogenital tuberculosis. This paper presents a report on 56 patients treated with rifampicin, ethambutol and isoniazid for 1 year. Therapy was started in hospital and continued on an ambulatory basis. Reconstructive surgery was carried out as early as 4-5 weeks after commencement of therapy, whereby only destroyed organs wee removed. Follow up continued at three-monthly intervals for a period of 2-5 years after completion of chemotherapy. All patients were cured.
Key concepts: Medicine, Ethambutol, Isoniazid, Rifampicin, Tuberculosis, Genitourinary system, Surgery, Ambulatory